| NSPT | Non-surgical periodontal therapy |
| SOD | Superoxide Dismutase |
| SOD1 | Superoxide Dismutase 1 |
| IRS2 | Insulin Receptor Substrate type 2 |
| IRS1 | Insulin Receptor Substrate type 1 |
| T2DM | Type 2 Diabetes Mellitus |
| mRNA | Messenger RNA |
| HbA1c | Glycated hemoglobin |
| PI3K-PKB | Phosphatidylinositol 3-kinase and protein kinase B |
| JNK-AP-1 | c-Jun N-terminal kinase-Activator Protein-1 |
| IKK-NF-kB | I kappa B kinase- Nuclear factor kappa-B |
| GLUT4 | Glucose transporter type 4 |
| Nrf2 | NF-E2-related factor 2 |
| Keap1 | Kelch-like ECH-associated protein |
| TC | Total Cholesterol |
| O2•− | Superoxide radical anion |
| H2O2 | Hydrogen peroxide |
| GPx | Glutathione peroxidase |
| ROS | Reactive oxygen species |
| TNF-α | Tumor necrosis factor-alpha |
| PBMCs | Peripheral blood mononuclear cells |
| TREND | Transparent Reporting of Evaluations with Nonrandomized Designs |
| ReBEC | Brazilian Clinical Trials Registry |
| HOMA | Homeostasis model assessment |
| IR | Insulin resistance |
| HDL-Cholesterol | High-density lipoprotein Cholesterol |
| LDL-Cholesterol | low-density lipoprotein cholesterol |
| vLDL | very-low-density lipoprotein |
| CVD | cardiovascular disease |
| VPI | Visible Plaque Index |
| MBI | Marginal Bleeding Index |
| BoP | Bleeding on Probing |
| PD | Probing Depth |
| CAL | Clinical Attachment Loss |
| XOD | Xanthine-xanthine oxidase |
| BSA | Bovine serum albumin |
| I.N.T. | 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride |